Chinese customers sold on 'elixir of youth' despite expert warnings

China is biggest source of NMN materials, largest buyer of end products

20240614 Caixin NMN

Despite lacking a breakthrough in human clinical trials, the global NMN market was forecast by a market research specialist in 2022 to reach over $400 million by 2028.

FAN QIAOJIA, WANG ZIPEI and KELLY WANG, Caixin

Chinese consumers have bought into the global craze for nicotinamide mononucleotide, or NMN, a product with supposed "anti-aging" properties that's been touted by sellers as an "elixir of youth," which has topped sales on cross-border e-commerce platforms in recent years.

Users mention improved sleep quality as one of its benefits, while others rave in online testimonials that it is a miracle remedy that boosts energy, sharpens hearing and vision and even accelerates nail growth. Despite lacking a breakthrough in human clinical trials, the global NMN market size was forecast to grow to over $400 million by 2028, market research firm Bosson Research in a 2022 report.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.